Molecular Targets of β-Lactam-Based Antimicrobials: Beyond the Usual Suspects
The common practice in antibacterial drug development has been to rapidly make an attempt to find ever-more stable and broad-spectrum variants for a particular antibiotic, once a drug resistance for that antibiotic is detected. We are now facing bacterial resistance toward our clinically relevant an...
Saved in:
Main Author: | Monika I. Konaklieva (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2014-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beyond the Usual Suspects: When the Skin Tells a Different Story: Cutaneous Metastasis in Prostate Carcinoma
by: Kumari Sweta Leena Patra, et al.
Published: (2024) -
Approaches to Testing Novel β-Lactam and β-Lactam Combination Agents in the Clinical Laboratory
by: Carmella Russo, et al.
Published: (2023) -
Fragment-Based Lead Discovery Strategies in Antimicrobial Drug Discovery
by: Monika I. Konaklieva, et al.
Published: (2023) -
β-Lactam Antibiotics Renaissance
by: Wenling Qin, et al.
Published: (2014) -
Role of AmpG in the resistance to β-lactam agents, including cephalosporins and carbapenems: candidate for a novel antimicrobial target
by: Roshan D'Souza, et al.
Published: (2021)